Home Computing Materialise Brings 3D Printed Patient Devices Closer to U.S. Point of Care

Materialise Brings 3D Printed Patient Devices Closer to U.S. Point of Care

by Amelia Ramiro

Materialise, a leading provider of 3D printing solutions, has opened a new facility in the United States to meet the increasing demand for personalized 3D printed medical devices. This dedicated facility will allow Materialise to respond more efficiently to requests from U.S. physicians for patient-specific medical devices, such as titanium cranio-maxillofacial (CMF) implants used in facial reconstruction surgery.

The decision to open a facility in the United States stems from the company’s commitment to expanding and growing the market. By establishing a facility within the country, Materialise can provide faster turnaround times to customers, clinicians, and patients. Time is of the essence when it comes to medical procedures, and Materialise aims to reduce the time it takes to deliver fully personalized implants to hospitals and patients throughout the U.S.

The new facility, located in Plymouth, Michigan, has been specifically designed to support the production of CMF implants. It has been equipped with metal 3D printers and post-processing equipment, which have different requirements compared to the polymer-based additive manufacturing (AM) production facilities already in place. This expansion complements Materialise’s existing manufacturing of 3D printed surgical guides and anatomical models on-site.

The use of 3D printing and advanced visualization techniques is revolutionizing personalized patient care. These technologies allow for the creation of medical devices that are closely matched to a patient’s anatomy, resulting in improved outcomes. Patient-specific 3D printed anatomical models are used for diagnostic purposes, while surgical guides enhance surgical procedure accuracy and efficiency. As 3D printing and anatomical modeling technologies become more powerful and widely available, their use in healthcare is increasing. Additionally, new insurance reimbursement models that focus on outcomes are also driving the adoption of these technologies.

Bryan Crutchfield, Vice President and General Manager of Materialise NA, explains that there is a change in mentality among U.S. medical providers, with a focus on accuracy and timeliness to ensure patient satisfaction and reduce readmissions. 3D printing and patient-specific implants play a crucial role in this shift, as they allow for thorough pre-procedure planning, increasing the likelihood of successful outcomes.

Materialise’s expansion in the United States is a significant step in meeting the growing demand for personalized 3D printed medical devices. Through this facility, the company aims to provide quicker access to patient-specific implants, ultimately improving patient care and outcomes. With advancements in 3D printing technology and increased adoption in healthcare, personalized medical devices are becoming more accessible, revolutionizing the field of medicine.

You may also like